Novoprotein Scientific Inc. (SHA:688137)
43.10
+2.05 (4.99%)
At close: Mar 10, 2026
Novoprotein Scientific Revenue
In the year 2025, Novoprotein Scientific had annual revenue of 151.51M CNY with 18.78% growth. Novoprotein Scientific had revenue of 39.66M in the quarter ending December 31, 2025, with 11.78% growth.
Revenue
151.51M
Revenue Growth
+18.78%
P/S Ratio
18.90
Revenue / Employee
267.69K
Employees
556
Market Cap
2.86B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Landfar Bio-medicine | 125.47M |
| Jiangsu Sihuan Bioengineering | 341.90M |
| Suzhou Fushilai Pharmaceutical | 439.57M |
| Shanghai Universal Biotech | 1.07B |
| Jilin Jian Yisheng Pharmaceutical | 639.10M |
| Shandong Sito Bio-technology | 954.76M |
| Shanghai Hile Bio-Technology | 246.35M |
| Cabio Biotech (Wuhan) | 574.88M |